Hair shedding that starts suddenly can feel alarming, but the timing and pattern often provide important clues. A noticeable increase in hair coming out several weeks after illness, major stress, hormonal change, or medication is different from gradual thinning that follows a predictable pattern.
Get Prescribed and get a licensed provider's guidance on what your shedding pattern means for your next step.
Telogen effluvium vs androgenetic alopecia describes two different causes of hair loss. Telogen effluvium usually causes diffuse shedding after a trigger and may improve when the trigger is addressed. Androgenetic alopecia causes gradual follicle miniaturization and typically needs ongoing management.
Understanding how the hair growth cycle changes during telogen effluvium is the first step toward distinguishing temporary shedding from progressive pattern loss.
What Is Telogen Effluvium?
Telogen effluvium is a nonscarring, reactive form of hair loss. It can develop after metabolic or physical stress, hormonal changes, illness, major life events, or certain medications. Unlike conditions that permanently damage the follicle, telogen effluvium typically causes diffuse shedding across the scalp rather than a single smooth bald patch. The trigger may be temporary, but the shedding often becomes noticeable weeks later, which can make the cause difficult to identify. Clinical reference from NCBI.
How the hair cycle changes
Hair follicles continually move through a growth phase called anagen, a transition phase, and a resting phase called telogen. In a healthy scalp, approximately 85% of follicles are in anagen and about 15% are in telogen. For a practical overview, see the guide to hair growth cycle stages.
A significant stressor can disrupt that balance. In some cases, severe stress may prematurely move up to 70% of hairs out of active growth and into telogen. As more follicles enter the resting phase together, the telogen proportion may rise to 30% or more. Those follicles do not all shed immediately. Instead, the delay in the cycle explains why someone may notice substantial hair fall two to three months after a fever. Surgery, rapid weight change, hormonal shift, medication change, or another trigger. Sources include clinical education from Hims and Plymouth Meeting Dermatology.
How long does it last?
Acute telogen effluvium is often self-limiting. When the underlying trigger is addressed and no other condition is contributing, shedding commonly improves over six to nine months. That timeline is not a guarantee, and visible density can take longer to change because new hairs must grow through the cycle before they become noticeable.
Sudden, diffuse shedding can also occur alongside androgenetic alopecia, so the pattern should not be diagnosed from timing alone. If hair loss continues, becomes patterned, or causes concern, a licensed provider can review your history, medications, symptoms, and scalp changes. A careful evaluation matters when comparing telogen effluvium vs androgenetic alopecia, because the conditions can overlap and require different management.
What Is Androgenetic Alopecia?
Androgenetic alopecia is a chronic, progressive form of hair loss influenced by genetics and the way susceptible follicles respond to dihydrotestosterone (DHT). Rather than causing one sudden shedding episode, it gradually reduces visible density as affected follicles become smaller and produce finer hair. This process is also called pattern hair loss.
How follicle miniaturization changes the hair
In a susceptible follicle, repeated growth cycles can produce a shorter, thinner shaft than the cycle before it. Over time, terminal hairs may become fine, short hairs that provide less coverage. This follicle miniaturization is a defining feature of androgenetic alopecia and can contribute to worsening density for 12 months or longer without treatment or other intervention. Clinical descriptions of androgenetic alopecia distinguish this gradual pattern from the abrupt shedding often associated with telogen effluvium.
Typical patterns in men and women
Androgenetic alopecia often begins gradually, frequently between the ages of 20 and 40, although timing varies. In men, early changes commonly appear as recession at the hairline, thinning at the temples, or reduced coverage at the crown. In women, thinning is more likely to be noticeable along the central part and across the top of the scalp, while the frontal hairline may remain relatively preserved. These are common patterns, not a substitute for an individual diagnosis.
The distribution can be subtle at first. Someone may notice more scalp showing under bright light, a wider part, or a ponytail that feels smaller before obvious bald areas develop. Because the process is gradual, it can be difficult to identify when it started. It may also occur alongside another type of shedding, including telogen effluvium, which can make the change appear more sudden. A qualified provider can evaluate the history, pattern, shedding, and follicle characteristics together.
To learn more about the factors involved, see our guide to androgenetic alopecia causes. Understanding whether the loss reflects progressive miniaturization, a temporary shedding trigger, or both is an important step toward choosing an appropriate, medically supervised plan.
Telogen Effluvium vs Androgenetic Alopecia and How They Differ
Telogen effluvium (TE) and androgenetic alopecia (AGA) can both reduce visible density, but they affect the hair cycle in different ways. TE is a reactive shedding process, while AGA involves gradual follicle miniaturization. The timing, distribution, and appearance of the shed hair can help a provider distinguish them, although both conditions may occur together.
| Feature | Telogen effluvium (TE) | Androgenetic alopecia (AGA) |
|---|---|---|
| Onset | Shedding usually starts suddenly, often 2 to 3 months after a triggering event. The delay reflects the time needed for affected follicles to enter the resting phase and release their hairs. Clinical overview of TE timing | Thinning generally develops gradually over months or years. AGA often begins between the 20s and 40s, although timing varies among individuals. Clinical overview of AGA onset |
| Trigger or mechanism | Common associations include significant stress, illness, hormonal changes, or medications. These factors can shift more follicles than usual into the telogen, or resting, phase. NCBI overview of telogen effluvium | Genetic susceptibility and androgen signaling, including sensitivity to DHT, progressively shrink affected follicles. This process produces shorter, finer hair shafts over time. Dermatology overview of follicle miniaturization |
| Distribution | Hair loss is usually diffuse, meaning it appears across much of the scalp rather than in one defined region. A wider part or reduced overall fullness may be more noticeable than a receding hairline. | Thinning is typically patterned, such as at the crown, hairline, or central part. The exact pattern differs between people and may also be influenced by sex and family history. |
| Amount and appearance of shed hair | Density can drop noticeably because the proportion of follicles in the telogen phase may rise from about 15% to 30% or more. This can lead to increased shedding, sometimes in handfuls. TE shedding and hair-cycle comparison | The primary issue is progressive miniaturization and thinning rather than a sudden surge in loose hairs. Individual strands may become shorter and finer as affected follicles produce smaller shafts. AGA miniaturization overview |
| Prognosis | TE is often self-limited and may resolve within 6 to 9 months after the underlying trigger is addressed. Though the timeline varies and regrowth may take longer to look full. | AGA is typically chronic and can continue progressing without appropriate management. Early evaluation can help clarify whether treatment is appropriate for the pattern and individual health history. |
The distinction is not always obvious from shedding alone. A sudden, all-over increase in hair loss after an illness or major stressor is more consistent with TE, while slowly evolving patterned thinning suggests AGA. Still, the conditions can coexist, so persistent shedding or continuing pattern loss deserves a clinical assessment rather than self-diagnosis.
How to Tell Telogen Effluvium From Androgenetic Alopecia
Only a licensed healthcare provider can confirm whether shedding reflects telogen effluvium (TE), androgenetic alopecia (AGA), another condition, or more than one process. Still, a careful home observation can help you describe what you are seeing during an online consultation. Look at the timing, distribution, and type of hairs you are losing rather than relying on a single day of shedding.
Start with the timing and distribution
TE often appears as noticeable, diffuse shedding across much of the scalp. It may begin about two to three months after a significant illness, metabolic stress, hormonal change, medication change, or another trigger. AGA generally develops more gradually, with progressive density loss and a recognizable pattern, such as widening at the part or thinning at the temples and crown. The hair shafts may also become progressively shorter and finer as follicles miniaturize.
These patterns are clues, not a diagnosis. Washing frequency, hair length, styling practices, and natural variation can all change how much hair you notice in a brush or drain. If you track shedding, use the same method for several days and note whether the change is sudden or steadily progressive.
What shed-hair length may suggest
A small, non-invasive self-check is to count a representative group of shed hairs and compare their lengths. Research describing a hair-count and hair-length method found that telogen vellus hairs measuring about 3 centimeters or shorter can point toward AGA. Because follicle miniaturization produces shorter, finer shafts. By contrast, longer hairs shed diffusely are more consistent with a telogen shedding pattern, although this observation cannot establish the cause on its own. Read the study on distinguishing chronic TE from AGA.
Do not pull hairs out to create a sample, and do not interpret one short hair as proof of pattern loss. Instead, record the broad pattern: Are most shed hairs long and similar to your usual strands, or are you seeing a meaningful number of very short, fine hairs? A provider may combine this history with scalp examination, dermoscopy, medical history, and selected testing.
When the two conditions overlap
TE and AGA can occur together, which makes self-assessment especially difficult. A temporary increase in shedding may make an underlying pattern of gradual thinning more visible. Conversely, ongoing shedding can make AGA seem more sudden than it is. Research notes that distinguishing the two is harder when they coexist, particularly when clinicians must weigh shedding volume alongside the presence of miniaturized hairs.
For women, diffuse shedding and widening at the part can have several possible explanations. An evaluation of female pattern hair loss can help place those changes in the right clinical context. Bring your timeline, medication and health changes, family history, and photos taken under consistent lighting to your consultation. That information gives a licensed provider a safer basis for deciding whether further evaluation or a personalized treatment plan is appropriate.
Can Telogen Effluvium Become Chronic?
Yes. Most telogen effluvium is self-limited, with shedding often improving within six to nine months after the underlying trigger is addressed. A less abrupt, chronic form can develop when shedding begins insidiously and continues beyond that usual recovery window. Persistent shedding does not automatically mean the condition has become permanent, but it does deserve a closer look at the pattern, timeline, and possible contributing factors.
What "chronic" means in telogen effluvium
Acute telogen effluvium commonly follows a physical or metabolic stressor, hormonal change, or medication exposure. Because hair follicles respond on a delay, noticeable shedding may appear two to three months after the event. In chronic telogen effluvium, the shedding is more gradual or continues at a low level for longer than six to nine months. The person may notice ongoing excess hair in the shower, on a brush, or around the home rather than one clearly defined episode.
Chronic does not describe the amount of hair lost on a single day. It describes the persistence and course of shedding. A provider may review recent illness, nutritional concerns, hormonal changes, medications, stress, and other health factors while also examining the scalp and hair shafts.
Why chronic TE can resemble androgenetic alopecia
Chronic telogen effluvium and androgenetic alopecia (AGA) are separate conditions, but they can look similar, particularly when they occur in the same person. Chronic shedding can make overall density appear reduced, while AGA gradually miniaturizes follicles and produces shorter, thinner hair shafts over time. Distinguishing telogen effluvium vs androgenetic alopecia can therefore require more than judging how much hair appears in the drain.
Research notes that the two conditions may be difficult to separate when they co-occur. Clinicians can consider shedding volume, the distribution of reduced density, and the presence of miniaturized or vellus hairs. In uncertain cases, specialized histomorphometric and immunohistochemical analysis can help confirm that chronic telogen effluvium and female pattern hair loss are distinct forms of alopecia. A PubMed study on differentiating chronic TE and AGA describes hair-length and shedding analysis as one noninvasive part of that evaluation, while a separate analysis supports their histologic distinction.
When ongoing shedding warrants evaluation
Consider speaking with a licensed provider if noticeable shedding persists beyond six to nine months. Returns repeatedly, or is accompanied by widening part lines, receding areas, patchy loss, scalp symptoms, or progressive thinning. Evaluation is also appropriate when the original trigger is unclear. Early assessment can help distinguish continued telogen shedding from AGA or another cause, so treatment decisions are based on the pattern rather than assumptions.
Treatment Approaches for Telogen Effluvium vs Androgenetic Alopecia
Treatment depends on why the follicles are shedding or becoming less productive. Telogen effluvium (TE) is often a temporary response to a trigger such as metabolic stress, hormonal change, or medication. When the trigger is identified and addressed, shedding commonly settles over time. TE may begin two to three months after the triggering event and often resolves within six to nine months, although the timeline varies by person and cause. Clinical evaluation is important when the trigger is unclear or shedding continues.
Managing telogen effluvium
For TE, the first treatment priority is finding and managing the underlying factor. A licensed provider may review recent illness, major stress, nutritional concerns, hormonal changes, medication use, and other relevant medical history. That review helps distinguish a reactive shedding episode from another form of hair loss and identifies whether additional evaluation may be appropriate.
Because TE reflects a disruption in the hair cycle, it is not automatically treated like pattern hair loss. Correcting a trigger does not produce an instant change in the appearance of the hair. Follicles need time to return to a stable growth pattern, and visible density may lag behind the reduction in shedding. Avoiding harsh styling practices and maintaining a balanced routine can support the scalp while the cause is addressed. But supplements or medications should not be started solely on the basis of a self-diagnosis.
Managing androgenetic alopecia
Androgenetic alopecia (AGA) involves gradual follicle miniaturization. Hair shafts can become shorter and thinner, with density gradually declining over time. Unlike many cases of TE, AGA is progressive and generally calls for ongoing management rather than a short course aimed at a single trigger. Treatment planning may focus on helping support existing follicles and slowing further loss. With the appropriate approach depending on the patient's health history, pattern of loss, and treatment goals.
Prescribed Essence offers clinically backed, personalized prescription options that may include compounded topical minoxidil or finasteride when medically appropriate. For some women with pattern hair loss, a provider may also consider spironolactone. Anyone researching female pattern hair loss should receive individualized guidance, since the cause and safe treatment options can differ among patients.
Why diagnosis comes before a treatment plan
TE and AGA can occur together, making the distinction more difficult. A treatment that may be reasonable for AGA is not a substitute for investigating a sudden shedding trigger. And treating a suspected trigger alone may not address underlying follicle miniaturization. Prescribed Essence begins with an online consultation, medical suitability screening, and licensed provider review. If prescription treatment is appropriate, the plan can be tailored and freshly compounded rather than selected as a one-size-fits-all product. No treatment guarantees regrowth, so the safest next step is an evaluation that matches the plan to the actual pattern and cause of hair loss.
When to Talk to a Provider About Your Hair Loss
Knowing when to seek medical guidance can help distinguish a temporary shedding episode from a pattern of progressive loss. The timing, distribution, and history of your shedding are useful clues, but they cannot replace an evaluation. Use the sequence below to prepare for a focused consultation.
-
Track when the shedding started
Write down when you first noticed more hair in the shower, on your brush, or on your clothing. Then consider whether a possible trigger occurred roughly two to three months earlier. Illness, significant stress, childbirth, hormonal changes, and medication changes can precede telogen effluvium. This delay happens because affected follicles enter a resting phase before the hairs are released. Telogen effluvium is often self-limited and may resolve within six to nine months after the trigger is addressed. But the timeline varies and the trigger may not be obvious. Review the clinical overview of telogen effluvium for additional background.
-
Describe the pattern, not just the amount
Note whether the loss appears diffuse, with shedding from across the scalp, or follows a more stable pattern. A widening part, reduced density at the crown, or a gradually receding hairline can suggest androgenetic alopecia, which involves progressive follicle miniaturization. A sudden increase in hair shed after a clear trigger may fit telogen effluvium more closely. These patterns can overlap, however. Telogen effluvium and androgenetic alopecia may occur together, making self-diagnosis especially unreliable. Take dated photos in consistent lighting if you are comfortable doing so, and bring a list of current medications and supplements.
-
Arrange a consultation if the change persists or progresses
Consider speaking with a provider if shedding continues beyond about six months, if your part is becoming wider, or if you see ongoing thinning despite no recent trigger. Persistent or insidious shedding beyond the usual six- to nine-month course may indicate chronic telogen effluvium, another cause, or coexisting pattern loss. You do not need to wait for severe loss before asking for help. Earlier evaluation can establish a useful baseline and clarify whether monitoring, trigger management, or treatment is appropriate.
-
Let the provider screen for underlying causes
A licensed provider should review the onset and pattern of loss, medical history, recent stressors or illness, medications, family history, and other relevant symptoms before recommending treatment. Depending on the situation, the evaluation may include scalp examination and testing for potential contributors. Because telogen effluvium and androgenetic alopecia require different management approaches, treatment should follow medical suitability screening rather than a one-size-fits-all product choice. An online consultation with Prescribed Essence includes digital assessment and licensed provider review before any personalized prescription plan is considered.
Frequently Asked Questions
What is the main difference between telogen effluvium and androgenetic alopecia?
Telogen effluvium usually causes sudden, diffuse shedding after a physical or metabolic trigger. Androgenetic alopecia is a gradual process in which susceptible follicles become smaller, producing progressively thinner hair and a patterned change in density.
Can telogen effluvium become chronic?
Yes. Telogen effluvium may be considered chronic when shedding develops gradually and persists beyond the usual 6 to 9 month recovery window. Ongoing shedding can also occur alongside androgenetic alopecia, so a provider may need to evaluate both possibilities rather than assume there is only one cause.
How do you distinguish telogen effluvium from female pattern hair loss?
Female pattern hair loss typically produces gradual widening or thinning in characteristic areas, while telogen effluvium more often causes a noticeable increase in shedding across the scalp. The conditions can overlap, so a clinical examination is more reliable than appearance alone.
Does telogen effluvium require treatment?
Often, management focuses on identifying and addressing the underlying trigger, after which shedding may settle. Androgenetic alopecia generally requires a longer-term treatment plan to manage follicle miniaturization. A licensed provider can assess medical suitability before recommending prescription options.
How long does telogen effluvium shedding usually last?
Shedding commonly begins about 2 to 3 months after a trigger and often resolves within 6 to 9 months once the trigger has been addressed. Persistent or worsening loss warrants evaluation, particularly if the scalp pattern suggests follicle miniaturization.
Start Your Hair Growth Plan Today
Hair loss is stressful, but you do not have to figure it out alone. Prescribed Essence pairs clinically backed treatments with one-to-one medical guidance, so you get care that fits your history and your goals. The process is simple: tell us about your hair, a licensed provider reviews your medical history, and a compounding pharmacist prepares a prescription tailored to you. No generic formulas, no guesswork, and no waiting rooms.
Every treatment is medically reviewed before it ships, and your plan can be adjusted as your hair responds. We are here to support you at every step, with honest guidance on what to expect.
Many people begin to see changes within months, but results vary from person to person. Your provider will help you set realistic expectations and track your progress along the way.
Get Prescribed and start your personalized, clinician-reviewed hair growth plan today.
